Oregon House Bill 2519 (Prior Session Legislation)

---

Completed Legislative Action
Spectrum: Moderate Partisan Bill (Democrat 4-1)
Status: Failed on July 7 2017 - 100% progression
Action: 2017-07-07 - In committee upon adjournment.
Text: Latest bill text (Introduced) [PDF]

Requires pharmacy to report de-identified information to prescription monitoring program upon dispensing prescribed naloxone. Requires pharmacy to report certain other identifying information to prescription monitoring program upon dispensing prescribed controlled substance classified in schedules II through IV. Requires information to be disclosed from prescription monitoring program to medical director or pharmacy director. Requires information to be disclosed from prescription monitoring program for certain other purposes. Requires licensing information of licensees who are authorized to prescribe or dispense controlled substances to be provided to Oregon Health Authority for purpose of qualifying licensees to report information to, or receive information from, prescription monitoring program. Becomes operative January 1, 2018. Declares emergency, effective on passage.

Relating to the program used to monitor the dispensing of prescription drugs; declaring an emergency.

Rep. Knute Buehler [R]	Rep. Alissa Keny-Guyer [D]	Rep. Robert Nosse [D]	Sen. Laurie Monnes Anderson [D]
Sen. Elizabeth Steiner Hayward [D]

Date	Chamber	Action
2017-07-07	House	In committee upon adjournment.
2017-01-17	House	Referred to Health Care.
2017-01-09	House	First reading. Referred to Speaker's desk.

Type	Source
Summary	https://olis.oregonlegislature.gov/liz/2017R1/Measures/Overview/HB2519
Text	https://olis.oregonlegislature.gov/liz/2017R1/Downloads/MeasureDocument/HB2519/Introduced